Medicamentos Inyectables
El Hospital “Dr. Augusto Essmann Burgos” requiere contar con un contrato de suministro de Medicamentos Inyectables por el periodo de 24 meses, en circunstancias que estos productos no fueran provistos por la Central de Abastecimiento de los Servicios de S
23 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 1540-1369-SE19 | 27-09-2019 | Grifols Chile S.A. | $1.666.000 |
| 1540-1387-SE19 | 27-09-2019 | Fresenius Kabi Chile Limitada | $91.630 |
| 1540-1386-SE19 | 27-09-2019 | Laboratorio Pasteur S.A. | $120.428 |
| 1540-1385-SE19 | 27-09-2019 | Laboratorio Chile S.A. | $1.023.400 |
| 1540-1373-SE19 | 27-09-2019 | Novo Nordisk Farmaceutica Limitada | $152.915 |
| 1540-1372-SE19 | 27-09-2019 | Winpharm SpA | $261.800 |
| 1540-1370-SE19 | 27-09-2019 | Pfizer Chile S.A. | $315.350 |
| 1540-1094-SE19 | 17-07-2019 | Laboratorio Chile S.A. | $1.023.400 |
| 1540-1095-SE19 | 17-07-2019 | Grifols Chile S.A. | $1.041.250 |
| 1540-765-SE19 | 14-05-2019 | Farmacia Reccius S.A. | $110.670 |
| 1540-764-SE19 | 14-05-2019 | Laboratorio Sanderson S.A. | $27.608 |
| 1540-590-SE19 | 09-04-2019 | Grifols Chile S.A. | $624.750 |
| 1540-592-SE19 | 09-04-2019 | Pfizer Chile S.A. | $404.600 |
| 1540-415-SE19 | 12-03-2019 | Laboratorio Chile S.A. | $1.279.250 |
| 1540-281-SE19 | 14-02-2019 | Fresenius Kabi Chile Limitada | $549.780 |
| 1540-280-SE19 | 14-02-2019 | Laboratorio Sanderson S.A. | $85.323 |
| 1540-52-SE19 | 17-01-2019 | Novofarma Service S.A. | $173.371 |
| 1540-53-SE19 | 17-01-2019 | Laboratorio Sanderson S.A. | $173.145 |
| 1540-1129-SE18 | 12-11-2018 | Winpharm SpA | $166.600 |
| 1540-1127-SE18 | 12-11-2018 | Laboratorio Sanderson S.A. | $204.323 |
| 1540-1121-SE18 | 12-11-2018 | Grifols Chile S.A. | $1.249.500 |
| 1540-1131-SE18 | 12-11-2018 | Laboratorio Chile S.A. | $767.550 |
| 1540-1031-SE18 | 11-10-2018 | Novo Nordisk Farmaceutica Limitada | $1.785.000 |
| 1540-1033-SE18 | 11-10-2018 | Laboratorio Sanderson S.A. | $65.450 |
| 1540-1032-SE18 | 11-10-2018 | Alpes Chemie S.A. | $1.206.660 |
| 1540-803-SE18 | 13-08-2018 | Novo Nordisk Farmaceutica Limitada | $297.500 |
| 1540-804-SE18 | 13-08-2018 | Winpharm SpA | $95.200 |
| 1540-621-SE18 | 20-06-2018 | Pfizer Chile S.A. | $208.250 |
| 1540-623-SE18 | 20-06-2018 | Alpes Chemie S.A. | $422.331 |
| 1540-618-SE18 | 20-06-2018 | Laboratorio Sanderson S.A. | $74.435 |
| 1540-527-SE18 | 31-05-2018 | Grifols Chile S.A. | $2.082.500 |
| 1540-466-SE18 | 09-05-2018 | Laboratorio Sanderson S.A. | $146.465 |
| 1540-463-SE18 | 09-05-2018 | Pfizer Chile S.A. | $921.060 |
| 1540-464-SE18 | 09-05-2018 | Novofarma Service S.A. | $173.371 |
| 1540-465-SE18 | 09-05-2018 | Alpes Chemie S.A. | $603.330 |
| 1540-442-SE18 | 08-05-2018 | Laboratorio Sanderson S.A. | $86.275 |
| 1540-384-SE18 | 19-04-2018 | Laboratorio Sanderson S.A. | $10.710 |
| 1540-379-SE18 | 17-04-2018 | Winpharm SpA | $183.260 |
| 1540-346-SE18 | 05-04-2018 | Laboratorio Sanderson S.A. | $86.275 |
| 1540-339-SE18 | 04-04-2018 | Laboratorio Sanderson S.A. | $113.764 |
| 1540-338-SE18 | 04-04-2018 | Novo Nordisk Farmaceutica Limitada | $1.373.498 |
| 1540-300-SE18 | 28-03-2018 | Winpharm SpA | $750.295 |
| 1540-299-SE18 | 28-03-2018 | Novo Nordisk Farmaceutica Limitada | $305.830 |
| 1540-298-SE18 | 28-03-2018 | Farmacia Reccius S.A. | $221.340 |
| 1540-297-SE18 | 28-03-2018 | Fresenius Kabi Chile Limitada | $458.150 |
| 1540-296-SE18 | 28-03-2018 | Alpes Chemie S.A. | $361.998 |
| 1540-303-SE18 | 28-03-2018 | Opko Chile S.A. | $594.703 |
| 1540-301-SE18 | 28-03-2018 | Pfizer Chile S.A. | $748.510 |
| 1540-728-SE17 | 23-03-2018 | Grifols Chile S.A. | $1.249.500 |
| 1540-720-SE17 | 13-12-2017 | Laboratorio Pasteur S.A. | $180.642 |
| 1540-722-SE17 | 05-12-2017 | Farmacia Reccius S.A. | $36.890 |
| 1540-721-SE17 | 05-12-2017 | Laboratorio Sanderson S.A. | $134.470 |
| 1540-730-SE17 | 05-12-2017 | Novofarma Service S.A. | $86.686 |
| 1540-724-SE17 | 05-12-2017 | Pfizer Chile S.A. | $205.870 |
Fuente original:ficha mercadopublico.cl
